Most knee OA studies have focused on cartilage, but increasing evidence shows that cartilage loss is preceded by or accompanied with other changes in cartilage, bone and other soft tissues. Scoring systems developed for non-cartilage changes are based on changes in the structure's MRI signal intensity as compared to normal. Preliminary data have shown that cartilage signal behavior separates normals from early OA. There is also evidence that subchondral bone and calcified cartilage vascularizes before cartilage loss and that calcified cartilage advances into noncalcified cartilage in the early phase of the disease. These events change the MRI signal intensity of the cartilage and underlying bone. Their longitudinal analysis would advance our understanding of OA. The Osteoarthritis Initiative (OAI) has a large clinical and radiological knee OA dataset. Only an automated approach would make such a large scale analysis feasible. We developed a fully automated, atlas based segmentation and analysis system to segment and analyze bones, cartilage and anatomic regions from knee MR image data. Here we compare the repeatability and reproducibility of the automated system and an expert radiologist for measuring average MRI signal intensity of cartilage and bone in several regions, as well as the within the tibiofemoral joint space.
. Relationship between the knee X-ray OA grade (G01, G2, and G34) and the urinary CTX-II level in male and female subjects (A: 40-59 years, B: 7-79 years; pre: pre-menopause, post: post-menopause). A statistical analysis was performed between different OA grade groups in each age group. **P<0.01.
Menopause and administration of bisphosphonate strongly affect values of these biomarkers as reported previously. It is quite interesting that urine CTX-II and NTX-I have a weak but positive correlation in both younger and elder groups in female. This indicates that cartilage degradation and bone resorption appear to develop in parallel. Purpose: Most knee OA studies have focused on cartilage, but increasing evidence shows that cartilage loss is preceded by or accompanied with other changes in cartilage, bone and other soft tissues. Scoring systems developed for non-cartilage changes are based on changes in the structure's MRI signal intensity as compared to normal. Preliminary data have shown that cartilage signal behavior separates normals from early OA. There is also evidence that subchondral bone and calcified cartilage vascularizes before cartilage loss and that calcified cartilage advances into noncalcified cartilage in the early phase of the disease. These events change the MRI signal intensity of the cartilage and underlying bone. Their longitudinal analysis would advance our understanding of OA. The Osteoarthritis Initiative (OAI) has a large clinical and radiological knee OA dataset. Only an automated approach would make such a large scale analysis feasible. We developed a fully automated, atlas based segmentation and analysis system to segment and analyze bones, cartilage and anatomic regions from knee MR image data. Here we compare the repeatability and reproducibility of the automated system and an expert radiologist for measuring average MRI signal intensity of cartilage and bone in several regions, as well as the within the tibiofemoral joint space.
AUTOMATED ATLAS BASED SEGMENTATION OF KNEE MR

Methods:
The atlas for the automated system was created by manually tracing five subjects' 3D DESS WE images from the 0.D1 OAI dataset and selecting the best performing atlas for further refinement and use. To test repeatability, 30 subjects' images from the OAI were randomly chosen and anonymized. Of these, 10 were randomly selected and anonymized creating 40 blinded images. Automated measurements were generated with a trimmed average of five segmentations using varying initial parameters. Reproducibility was tested with 38 anonymized sagittal 3D DESS WE image sets of 19 subjects' scan-rescan studies from the OAI pilot study. These were segmented both semi-manually and automatically as in the repeatability test. Average signal intensity was automatically calculated for cartilage and bone in various regions as well as the tibiofemoral joint space. Reproducibility was calculated by computing mean-square (RMS) coefficient of variation (CV %) for each parameter. Results: Automated segmentation produced identical re-analysis results for all measured parameters. CV% for manual segmentation varied between 2.3%-10%. Scan-rescan reproducibility for the automated method varied from 1.75% -3.01%. Average signal intensities of cartilage plates were generally lower for tibia than for femur. Signal intensity of the deep layer of cartilage varied from 96 to 201, being higher for femur than for tibia. Average signal intensity of the superficial layer of subchondral bone was considerably lower for all areas. Reproducibility for tibiofemoral joint space signal intensity was 2.34% for lateral and 1.57 % for medial inter-bone regions using automated tools compared to 3.42 % and 3.34 % for manually edited regions.
Conclusions:
The automated atlas based MR image analysis system provided repeatable and highly reproducible signal intensity measurements in the medial and lateral weight bearing regions of the knee. These automated tools provide a realistic opportunity to characterize the behavior of structural and compositional changes in cartilage and non-cartilage tissues in OA by analyzing large populations such as the OAI or other longitudinal datasets. Purpose: The objective evaluation of the OA stage will help in the development and evaluation of effective OA treatments. The purpose of this work is to develop and evaluate a multivariate quantitative image-based biomarker as a surrogate measurement of the OA stage using the publicly available OAI data sets. Methods: OAI image data releases 0.D.1, 1.D.1, 2.D.1 and 3.C.1 were used in this study. OAI Biomarker0x, Joint0x, and Physicalexam0x datasets were also used. All right knee MRI DESS images of these data sets were automatically segmented and quantified five times using iPAS (Jose Tamez-Pena). The automated atlas-based segmentation extracted bone as well as cartilage tissue present in the knee joint using the 4Qimaging Knee Atlas (4QImaging, Rochester, NY). The extracted tissue included definitions of the trochlea, and the medial and lateral weight bearing areas of the knee. Once the tissues were automatically segmented, measurements of volume, thickness, bone curvature, average boundary signal and inter-bone distances were computed for all regions and for all time points. All repeated measurements from each of the five runs were then exported to Excel (Microsoft) with the RExcel add-in (Erich Neuwirth). Excel was then used to identify all the subjects with a full set of successful measure-ments for all four time points. Each one of the five repeated measurement were then summarized with the trimmed average (Average of the three middle measurements). The trimmed average measurements were used to compute the standardized femur curvature, the standardized minimum contrast, and the standardized minimum of medial and lateral tibia-to-femur bone distance. Those measurements were used as surrogated measurements for bone shape, tissue inflammation and unloaded tibia-femoral join distance. Those measurements then were used to compute a tree variable linear composite metric associated to the OA grade (biomarker00 data set) and to the total WOMAC score of the right knee (Joint0x data set). The weights of the linear combination of three variables were selected in such a way to provide a strong association to the total WOMAC score and the OA Grade score. The qMRI composite index then was evaluated for responsiveness to time using a linear model. Results: From 196 subjects included in data release 3.C.1, only 179 subjects had the complete set of four time points with full MRI quantification. The computed qMRI composite index was associated to total WOMAC (r=0.33, t=4.6, p<0.001) and to the OAgrade scores (Spearman rho=0.51, p<0.001). The coefficients of the linear model are shown in Table 1 . The linear model of the responsiveness of the qMRI composite index reduced the longitudinal variability of the index in 12%. (r 2 =0.116, p<0.001). The index had an average annualized SRM of 0.14 for the 179 subjects. 
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Conclusions:
The image-analysis methodology and biomarker discovery approach presented in this work was able to automatically segment the OAI DESS images and used to provide an objective index of the OA stage that is associated to the WOMAC scores and to the OA grade scores. Furthermore, this index has the potential to be used for automated objective screening for OA progressors. The methodology has still to be validated using more time points. It effectiveness and usefulness has still to be tested in independent OA study cohorts. Purpose: To analyze the influence of mitochondrial DNA (mtDNA) haplogroups on serum levels of molecular biomarkers in patients with osteoarthritis (OA).
MITOCHONDRIAL DNA HAPLOGROUPS MODULATE THE SERUM LEVELS OF BIOMARKERS IN PATIENTS WITH OSTEOARTHRITIS
Methods:
We analyzed serum levels of molecular biomarkers of cartilage metabolism (collagen type II markers: Coll2-1, Coll2-1NO 2 , C2C, CPII), synovial metabolism (hyaluronic acid (HA)) and cartilage and synovial turnover (YKL-40) in 73 OA cases and 77 healthy controls using enzyme-linked immunosorbent assays (ELISAs). All subjects had been previously genotyped for the mtDNA haplogroups J, U, and H. Non-parametric and multivariate analysis were performed to test the effects of the clinical variables, including gender, age, smoking status, diagnosis, mtDNA haplogroups and radiologic Kellgren/Lawrence (K/L) grade on the serum levels of the molecular markers.
Results: Non parametric analysis showed increased serum levels of HA in patients with OA, meanwhile the values for Coll2-1, C2C and C2C/CPII ratio appeared statistically increased in healthy controls. Multivariate analysis showed a clear incidence of the mtDNA haplogroups in the serum levels of the typical type II collagen markers. Carriers of the mtDNA haplogroup H had higher levels and carriers of the mtDNA haplogroup J showed lower levels. Statistical interactions between mtDNA haplogroups and both diagnosis and radiologic K/L grade in the serum levels of the molecular markers were also detected.
Conclusions:
A new role for mtDNA haplogroups emerges from this work. Our results suggest that the mtDNA haplogroups significantly interact with the serum levels of OA-related molecular markers, suggesting the possibility of their use as a complementary assay with these molecular markers. Purpose: Age-related changes in articular cartilage are likely to play a role in the aetiology of osteoarthritis (OA). One of the major age-related changes in cartilage is the accumulation of advanced glycation endproducts (AGEs). Pentosidine is considered to be an adequate marker for the many AGEs formed in vivo. The best way to study the effect of pentosidine on the development of OA is by taking cartilage biopsies. However, this may interfere with the disease process. Therefore, other sources need to be found to overcome this problem. Skin and urine pentosidine may be used as surrogate marker for cartilage pentosidine. The present study describes the presence of AGE in skin and urine in relation to OA severity, in a cohort of patients with very early signs of knee and/or hip OA (CHECK). Methods: Paired skin and cartilage samples were obtained postmortem (n=17). Furthermore, paired skin and urine samples were obtained from a cohort of 300 patients with knee and/or hip pain being part of the Dutch CHECK cohort. Since urine pentosidine levels can vary in time due to diet variation, urine was collected at 2 different time points with 3 month time interval. Levels of pentosidine as AGE marker were measured in digested skin samples and urine by HPLC. X-rays of both knees (weight bearing, semi flexed) and hips (weight bearing, AP) were made of all patients and scored according to Kellgren and Lawrence (K&L) . Results: Cartilage pentosidine correlates well with skin pentosidine (R=0.473, p≤0.001). Of 205 patients all data could be collected. The number of patients with a K&L grade 0 to 8 of the sum of the 4 joints was 67, 57, 34, 15, 21, 3, 4, 2, and 2. Skin pentosidine was higher in mild (total KL ≥ 4) compared to low (total KL ≤ 3) radiographic OA (p<0.05). A marginal but statistical significant correlation of skin pentosidine levels with the sum K&L score was found. Separating hips and knees, the pentosidine relation with severity of radiographic OA was found for the knee but not for the hip. Skin and urine pentosidine levels correlate marginal (R=0.285, p≤0.05). For urine pentosidine, no difference could be found between mild and low radiographic OA, even not when separating hips and knees. Age, creatinine clearance, gen-
SKIN AND URINE PENTOSIDINE AS MARKERS OF RADIOGRAPHIC JOINT DAMAGE IN EARLY OSTEOARTHRITIS
